G01N 2333/70546
Integrin superfamily
Official title: Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
G01N2333/70546 (Integrin superfamily) appears on 208 US grants and 448 published applications in this corpus.
Search patents in G01N- Granted patents
- 208
- Published applications
- 448
- Assignees
- 236
- Inventors
- 765
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 5 | 2 |
| 2002 | 6 | 12 |
| 2003 | 6 | 15 |
| 2004 | 2 | 15 |
| 2005 | 4 | 9 |
| 2006 | 3 | 12 |
| 2007 | 5 | 26 |
| 2008 | 5 | 12 |
| 2009 | 5 | 20 |
| 2010 | 9 | 17 |
| 2011 | 14 | 22 |
| 2012 | 11 | 18 |
| 2013 | 7 | 16 |
| 2014 | 14 | 25 |
| 2015 | 12 | 43 |
| 2016 | 13 | 28 |
| 2017 | 9 | 17 |
| 2018 | 10 | 27 |
| 2019 | 10 | 10 |
| 2020 | 10 | 17 |
| 2021 | 9 | 13 |
| 2022 | 4 | 20 |
| 2023 | 8 | 16 |
| 2024 | 4 | 9 |
| 2025 | 8 | 13 |
| 2026 | 5 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods for determining differences in alpha-4 integrin activity by correlating differences in sVCAM and/or sMAdCAM levels25 Aug 2026US 12,716,899 B2Biogen MA Inc.
- Methods of detecting markers for inflammatory conditions and food sensitivity in companion animals19 May 2026US 12,631,652 B2Vetica Labs, Inc.
- Methods for treating drug resistant cancers14 Apr 2026US 12,601,743 B2The Regents of the University of California
- TCR-independent molecular identification of mutation-related and tumor-specific T cells17 Mar 2026US 12,578,332 B2Medizinische Hochschule Hannover
- Compositions and methods for treatment24 Feb 2026US 12,558,350 B2Bausch + Lomb Ireland Limited
- Compositions and methods involving integrin alpha3beta11 Oct 2026US 2026/0297198 A1149 Bio, LLC
- Use of integrin a5b1 as target in screening of drugs for preventing and/or treating bone loss23 Jul 2026US 2026/0207645 A1The Hong Kong Polytechnic University
- Anti-alpha5 integrin antibodies and uses thereof9 Jul 2026US 2026/0193361 A1Pasithea Therapeutics Corp.
- Examination method for immune-related adverse event enteritis28 May 2026US 2026/0146996 A1Kinki University
- P-selectin mutants and modulation of integrin-mediated signaling21 May 2026US 2026/0139028 A1The Regents of the University of California
Most cited
By later US patents
- Anti-integrin antibodies, compositions, methods and uses101US 7,163,681 B2Centocor, Inc. · 2007
- Compositions and methods for treatment of eye disorders84US 8,168,655 B2Sarcode Bioscience Inc. · 2012
- Anti-integrin antibodies, compositions, methods and uses60US 7,550,142 B2Centocor, Inc. · 2009
- Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies55US 8,246,958 B2Elan Pharmaceuticals, Inc. · 2012
- Anti-integrin antibodies, compositions, methods and uses52US 8,071,729 B2Centocor, Inc. · 2011